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Abstract
Lung macrophages are an important defence against respiratory viral infection and recent
work has demonstrated that influenza-induced macrophage PDL1 expression in the murine
lung leads to rapid modulation of CD8+ T cell responses via the PD1 receptor. This PD1/
PDL1 pathway may downregulate acute inflammatory responses to prevent tissue damage.
The aim of this study was to investigate the mechanisms of PDL1 regulation by human mac-
rophages in response to viral infection. Ex-vivo viral infection models using influenza and
RSV were established in human lung explants, isolated lung macrophages and monocyte-
derived macrophages (MDM) and analysed by flow cytometry and RT-PCR. Incubation of
lung explants, lung macrophages and MDM with X31 resulted in mean cellular infection
rates of 18%, 18% and 29% respectively. Viral infection significantly increased cell surface
expression of PDL1 on explant macrophages, lung macrophages and MDM but not explant
epithelial cells. Infected MDM induced IFNγ release from autologous CD8+ T cells, an effect
enhanced by PDL1 blockade. We observed increases in PDL1 mRNA and IFNβmRNA and
protein release by MDM in response to influenza infection. Knockdown of IFNβ by siRNA,
resulted in a 37.5% reduction in IFNβ gene expression in response to infection, and a signif-
icant decrease in PDL1 mRNA. Furthermore, when MDM were incubated with IFNβ, this cy-
tokine caused increased expression of PDL1 mRNA. These data indicate that human
macrophage PDL1 expression modulates CD8+ cell IFNγ release in response to virus and
that this expression is regulated by autologous IFNβ production.
Introduction
The optimal immune response to respiratory viral infections requires a coordinated and bal-
anced response from an array of innate and adaptive responses. Although the influenza virus
primarily infects the respiratory epithelium, this virus can also infect and replicate in human al-
veolar macrophages[1–3]. Macrophages are not only a key line of defence in the respiratory
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tract, responsible for phagocytosis and clearance of infectious organisms but are also orchestra-
tors of the adaptive immune response through presentation of antigen and by the cytokines
they release[4,5]. Direct infection of airway macrophages has been postulated as a key mecha-
nism in the development of secondary bacterial infection of the airway leading to consequent
pneumonia as described in 1918 influenza pandemic cases[3]. It has also been hypothesised
that the mortality associated with novel strains of influenza (e.g. H5N1), is due to increases in
macrophage cytokine release[6] highlighting a key role in the control of the
inflammatory response.
Recent studies have suggested that macrophage expression of Programmed Death Ligand
(PDL)-1 is important in regulating T cell responses to influenza infection[7]. PDL1 is the li-
gand for the Programmed Cell Death (PD) receptor 1, which is a member of the CD28 family
of T cell receptors with CD80 and CD86 being ligands for CD28. In the standard model of
T cell receptor (TCR) activation, activation of CD28 provides a necessary co-stimulation to
prevent T cell anergy[8]. In contrast, binding of PDL1 to PD1 causes inhibition of TCR-medi-
ated phosphatidylinositol-3-kinase (PI3Kinase) activation leading to inhibition of T cell prolif-
eration and cytokine release[9]. The increased expression and activation of the PD1/PDL1 axis
in chronic viral infections such as HIV and Hepatitis C (HCV) can lead to progressive loss of
T cell function[10,11]. However, it was only recently that a role for this PD1/PDL1 pathway
has been elucidated in the control of immune function in acute infections and increased PDL1
expression in response to pathogens was demonstrated to be crucial for impairment of CD8 cy-
totoxicity[7] and the development of regulatory T cells[12]. We have recently demonstrated
that CD4 cytotoxic T cells play an important role in protecting against severe influenza infec-
tion. This work demonstrated an additional role for MHC class II expressing cells and T helper
cell responses[13] highlighting the potential importance of macrophage-T cell interactions in
the control of influenza infection.
Whilst PDL1 expression has been shown to be increased on human airway macrophages in
response to respiratory viral infections[7], the mechanisms of the expression of this ligand on
macrophages in response to influenza has not been fully elucidated. Therefore we used a vali-
dated ex vivo human lung model of influenza infection[14], where we have demonstrated infec-
tion of resected lung tissue using immunohistochemistry and flow cytometry, by the
expression of viral nucleoprotein (NP)-1[14]. In this ex vivomodel we have observed NP1 posi-
tivity only in epithelial cells and macrophages suggesting that these are the two major cell types
for which the virus has tropism. In addition to explant tissue we have used lung macrophages
and monocyte-derived macrophages (MDM)[15,16] to further explore the effects of influenza
infection on macrophage expression of PDL1.
Materials and Methods
Ethics
The collection of lung tissue and blood was approved by and performed in accordance with the
ethical standards of the Southampton and South West Hampshire Research Ethics Committee
(LREC no: 09/H0504/109 for tissue and 08/H0504/138 for blood). Written informed consent
was obtained from all participants.
Ex vivo infection of lung parenchymal tissue
Resected human lung tissue was obtained from patients undergoing airway re-section surgery
at our regional thoracic surgical unit. Ex vivo infection of resected lung tissue was carried out
as previously described[14].
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Lung macrophage isolation
Parenchymal tissue, distant from the resection margin and any gross pathology, was dissected
from the lobe and stored briefly in PBS (maximum 30 min) during transport to the laboratory
and macrophages were isolated according to previously published protocols[38].
Monocyte Isolation & differentiation
Monocytes were isolated from human peripheral blood mononuclear cells (PBMC) and differ-
entiated into macrophages as previously described[17].
Isolation of CD8+ T cells
CD8+ T cells were isolated from the monocyte-depleted PBMC suspension using CD8+
microbeads (Miltenyi-Biotec, Bisley, UK) according to the manufacturer’s instructions. CD8+
T cells that resulted from this separation step were frozen at -80°C in 10% (v/v) DMSO/HI-
FBS for use in later ELISpot analysis.
Infection of lung macrophages and MDMs
Influenza A virus strain X31 was supplied at a concentration of 4 x 107 pfu/ml (a kind gift of
3VBiosciences). Inactivated virus (UVX31) was prepared by exposure of the X31 to an ultra-
violet (UV) light source for 2 h. Macrophages were incubated for 2 h with no virus, or 4000 pfu
(lung) or 500 pfu (MDM) of X31 or UVX31. Cells were then washed and incubated for a fur-
ther 22 h at 37°C, 5% CO2. Supernatants were harvested for cytokine analysis, HA shedding
and LDH assays. Cells were collected using non-enzymatic cell dissociation solution (Sigma,
Poole, UK) for immediate flow cytometry analysis or lysed and stored at -80°C for
RNA analysis.
A similar method was used to infect MDM with Respiratory Syncytial Virus (RSV—strain
M37—Meridian Life Science Inc, Memphis, USA). Inactivated RSV (UV-RSV) was prepared
by exposure of the X31 to an ultra-violet (UV) light source for 2 h. 500 μl of stock RSV (3.5 x
106 pfu) was diluted 1:1 in basal RPMI; and a 1:10 dilution was made in each well and incubat-
ed for 2 h at 37°C. MDMs were then washed with basal RPMI and cultured in RS RPMI for a
further 22 h.
Flow cytometry analysis
Samples were resuspended in FACS buffer (PBS, 0.5% w/v BSA, 2 mM EDTA) containing
2 mg/ml human IgG before being incubated on ice in the dark for 30 min in the presence of
fluorescently-labelled antibodies or isotype controls (all BD Biosciences, Oxford, UK). Intracel-
lular staining for viral nucleoprotein (NP)-1, was performed using BD Cytofix/Cytoperm kit
according to manufacturer’s instructions, and AlexaFluor 488 (AF488)-conjugated anti-NP1
antibody (HB-65, a kind gift of 3VBiosciences). Flow cytometric analysis was performed on a
FACSAria using FACSDiva software v5.0.3 (all BD).
ELISpot
MDMwere either not infected, or were treated with 2.5 x 104 pfu/ml X31 Influenza A H3N2
virus at 37°C for 2 h prior to loading on a 1-DIK antibody (MabTech, Stockholm, Sweden)
coated 0.45 μmMultiScreen-IP Filter Plates (Millipore, Watford, UK) at a concentration of 5 x
104 MDM/well. 2.5 x 105 monocyte-depleted PBMC or 1 x 105 CD8+ T cells were then added
to MDM-containing wells in the presence or absence of anti-PDL1 or isotype control antibod-
ies (10 μg/ml—eBiosciences) and incubated at 37°C for a further 22 h. ELISpot was then carried
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out according to manufacturer’s instructions (MabTech). In initial experiments, no IFNγ stain-
ing was seen in wells containing infected MDM or lymphocytes alone (data not shown). Pe-
ripheral blood T cells do not appear to be infected when exposed to X31 (S3 Fig.).
siRNA experiments
After isolation, monocytes were cultured in GM-CSF media as described above for 11 d before
cells were washed with basal RPMI. One hundred microliters of GM-CSF media was added to
the cultures before incubating with 50 nM scrambled siRNA or siRNA specific to IFNβ using
6 μl HiPerFect (Qiagen, Manchester, UK) for 24 h in GM-CSF media. MDMwere subsequently
infected with influenza as previously described and IFNβ and PDL1 mRNA expression were
analysed using RT-PCR.
RNA Isolation & RT-PCR
RNA was extracted from macrophages using a Stratagene Microprep Kit. Reverse transcription
was carried out using a nanoScript Reverse Transcriptase kit and PCR amplifications for cyto-
kine gene expression (IFNα, IFNβ, IFNγ, IL10, PDL1) were performed. Gene expression was
normalized to β2-microglobulin gene expression and quantified using the ΔΔ CT method.
Supernatant analyses
IFNβ concentrations in culture supernatants were measured by ELISA according to the manu-
facturer’s instructions (MSD, Gaithersberg, USA). Culture supernatants were analysed by
Luminex assay as per manufacturer’s instructions (Bio-Rad). LDH release was measured using
CytoTox 96 Non-Radioactivity Cytotoxicity Assay according to the manufacturer’s instruc-
tions (Promega, Southampton, UK). Release of viral hemagglutinin was measured using a dot
blot assay on nitrocellulose membrane detected using a rabbit polyclonal anti-influenza serum.
The bound rabbit antibodies were detected using the Bio-Rad anti-Rabbit HRP detection sys-
tem according to the manufacturer’s instructions.
Statistics
Statistical analyses were performed using a paired Student’s t-test (GraphPad Prism v6, Graph-
Pad Software Inc., San Diego, USA). Results were considered significant if p<0.05.
For a full description of all the methods used please see S1 Methods.
Results
Influenza infection of lung explants increases macrophage PDL1
expression
Using the flow cytometry gating strategy we optimised for detection of epithelial cells (EpCAM
+) and macrophages (CD45+HLA-DR+—Fig. 1) in the lung explants we quantified the per-
centage of cells that expressed NP1 in each of these cell types. Approximately 32% of macro-
phages expressed NP1, as did a mean of 16% of epithelial cells (Fig. 2A & B). This staining was
specific to infection and viral replication and not just uptake or binding of the virus to the cell
surface, as NP1 staining was not increased above baseline when tissue was incubated with UV-
irradiated virus (Fig. 2A & B).
In the same samples we could also analyse the epithelial and macrophage PDL1 expression
induced by influenza infection. Prior to infection PDL1 expression was broadly expressed by
all the cells in both populations as assessed by comparison to isotype control staining. Macro-
phages expressed more than double the amount of PDL1 (specific mean fluorescence intensity
Viral Infection of Human Lung Macrophages
PLOS ONE | DOI:10.1371/journal.pone.0121527 March 16, 2015 4 / 16
Fig 1. Ex vivo infection of human lung explants. After resting explanted lung tissue overnight, 1 x 106 pfu/ml H3N2 X31 influenza virus or a UV-irradiated
aliquot of virus (UVX31) was added for 2 h. After washing, media was replaced and the tissue was incubated for a further 22 h followed by collagenase
digestion and flow cytometry analysisA)Gating strategy for identification of CD45+HLADR+ macrophages and CD45-EpCAM+ epithelial cells expressing
viral NP1 and PDL1 from lung tissue. B) FACS plots demonstrating increases in influenza infection (NP1) with corresponding increases in PDL1 expression.
Plots are representative of nine independent experiments.
doi:10.1371/journal.pone.0121527.g001
Fig 2. Quantification of infection of human lung explants. Histograms showing flow cytometry data of
viral NP1 (% cells) and PDL1 expression (specific mean fluorescence intensity—SMFI) in epithelial cells (A &
C) and macrophages (B & D).Data are expressed as means ±SE of 9 independent experiments. Data
analysed using a paired t-test ** p<0.01. **** p<0.0001.
doi:10.1371/journal.pone.0121527.g002
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(SMFI) 255) compared to epithelial cells (SMFI 102). Upon exposure to virus there was no sig-
nificant increase in epithelial PDL1 expression (Fig. 1B & 2C). In contrast there was a signifi-
cant increase in PDL1 expression by macrophages infected with X31 and cells exposed to the
UV-inactivated virus (Fig. 1B & 2D).
Isolated lung macrophages also express PD-L1 in response to
X31infection
To further assess whether this increase in PDL1 expression was due to the tissue milieu or spe-
cific to macrophage infection alone, we infected lung macrophages washed out of resected tis-
sue and isolated cells using adherence to plastic. Using non-infected (NI) cells to set a gate for
detection of>1% we observed significant numbers of lung macrophages (mean 18%) express-
ing NP1 compared to both NI and cells exposed to UV-inactivated virus (UVX31—mean 1.7%
—Fig. 3A). Infection of the macrophages also caused a significant increase in macrophage acti-
vation as assessed by cell surface expression of HLA-DR (Fig. 3B).
In contrast to explant macrophages, prior to infection, isolated lung macrophages expressed
little or no PDL1, suggesting that basal PDL1 expression is sustained by the tissue microenviron-
ment. Despite this low basal expression, PDL1 could still be significantly increased in response
to live virus but not to UVX31 (Fig. 3C). Expression of PDL1 however was not limited to the
cells co-expressing NP1 (Fig. 3D), suggesting that soluble mediators released by the infected
cells were responsible for the upregulation of PDL1 on the whole population of macrophages.
MDM respond to influenza infection similarly to lung macrophages
As the number of macrophages that could be isolated from tissue explants was a potential lim-
iting factor in our study, we generated MDM as previously described[17] to model lung macro-
phages and assessed whether MDM responded similarly to tissue-derived cells. In initial
experiments, the concentration of virus used was titrated to minimise virus-induced toxicity as
measured by LDH release into the supernatant and to give similar levels of infection seen in tis-
sue macrophages (see S1 Fig.).
Using flow cytometry, we detected significant amounts of NP1 expression in X31-exposed
MDM after 22 h, but not from UVX31- exposed cells (Fig. 4A). At the same time, we observed
significant HA release into the culture media from X31-infected cells after 22 h compared to
MDM infected for 2 h, but not from cells treated with UVX31 (Fig. 4B). As the dose of virus
used was associated with minimal cell death (S1B Fig.), these data suggest that not only is viral
replication occurring in MDM but that new virus is being shed from the surface of these cells.
Similarly to explant macrophages, we observed low basal levels of PDL1 on the MDM cell
surface and this expression was significantly increased in response to infection with X31 but
not UV-inactivated virus (Fig. 4D). Expression of the MHC class II molecule, HLA-DR, was
also significantly increased upon infection of MDM with X31 as was CD86 (Fig. 4C and
S1C Fig.), suggesting activation and upregulation of antigen-presentation pathways in these
cells. In contrast, the expression of CD14 and PDL2 was not significantly altered in response to
viral infection (S1D & E Fig.).
In order to discover if influenza infection increased PDL1 surface expression on MDM by
activating PDL1 gene expression, we analysed RNA isolated fromMDM infected with UV-in-
activated or live virus for 24 h by RT-PCR. Viral infection caused a significant 6.4-fold increase
in the steady-state levels of PDL1 mRNA when compared to uninfected cells and exposure to
UVX31 did not lead to an increase in expression of this gene (Fig. 4E). Moreover, this effect
was not limited to influenza, as infecting the MDM with respiratory syncytial virus (RSV) also
increased PDL1 expression (S2 Fig.).
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Functional consequence of virus-induced PDL1 expression
To assess the functional significance of this virus-induced PDL1 expression by macrophages, we
co-cultured autologous lymphocytes with influenza infected macrophages and analysed IFNγ re-
lease using ELISpot (Fig. 5). X31-infected MDM elicited significantly greater IFNγ release than
uninfected or UVX31-exposed cells (Fig. 5A) although there was a trend for greater IFNγ release
from autologous lymphocytes co-incubated with UVX31-exposed cells compared to uninfected
Fig 3. Infection of human lungmacrophages by X31.Human lung macrophages were isolated by plate adherence prior to infection with 4000 pfu/ml of
H3N2 X31 influenza virus or a UV-irradiated aliquot of virus (UVX31) for 2 h. After washing, media was replaced and the cells incubated for a further 22 h
before supernatants and cells were harvested. Cells were analysed for intracellular viral NP1 expression or cell surface expression of HLA-DR and PD-L1
using flow cytometry. Histograms showing flow cytometry data of A) Viral NP1 expression (% cells),B) HLA-DR expression (specific mean fluorescence
intensity—SMFI) andC) PDL1 expression (SMFI) from isolated human lung macrophages are expressed as means ±SE of 4 independent experiments. D)
Representative histograms demonstrating increase in PDL1 expression in response to influenza infection are shown. Data analysed using a paired t-test *
p<0.05, ** p<0.01.
doi:10.1371/journal.pone.0121527.g003
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cultures (p = 0.0659). We extended these investigations by incubating the infected macrophages
with autologous CD8+ T cells and again observed a significant increase in the amount of IFNγ
detected (Fig. 5B). Moreover, the amount of IFNγ released by autologous T cells was significant-
ly enhanced when the infected MDM-CD8+ cell cultures from every donor were incubated in
the presence of a PDL1 blocking antibody (10 μg/ml), when compared to incubating with an iso-
type control antibody (Fig. 5C). These data suggest that the PDL1 on the macrophage surface is
negatively regulating CD8+ T cell activation in line with previous investigations [7].
Influenza infection induces pro-inflammatory cytokine expression in
MDM
The observation that increased macrophage PDL1 expression was not limited solely to NP1
+ cells, suggested that soluble factors released by the infected cells were responsible for the
up-regulation of PDL1. Since the release and expression of interferons (IFNs) is the arche-
typal response to viral infection we therefore investigated the expression of these cytokines
by MDM infected with X31.
MDM were exposed to virus for 2 h, washed and lysed immediately or media replaced and
incubated for a further 22 h before cell lysis. IFNγ gene expression was below the limit of detec-
tion (>40 cycles) at both time points in these experiments and was not detectable in any of the
MDM culture supernatants in line with our ELISpot data (data not shown). In contrast IFNβ,
was elevated after infection with X31 for 2 h (data not shown), and this expression was signifi-
cantly increased after 24 h infection (Fig. 6A). Relative induction of IFNα was lower than IFNβ
but followed a similar pattern with significant expression after infection for 24 h. No IFNβ
Fig 4. Infection of MDMs by X31.MDMwere differentiated in the presence of 2 ng/ml GM-CSF for 12 d prior
to infection with 500 pfu/ml of H3N2 X31 influenza virus or a UV-irradiated aliquot of virus (UVX31) for 2 h.
After washing, media was replaced and the cells incubated for a further 22 h before supernatants and cells
were harvested. Cells were analysed using flow cytometry and RT-PCR, supernatant was analysed using dot
blot. Histograms showing infected MDM expression of A) Viral NP1 expression (% cells n = 7), B) release of
hemagglutinin into supernatants (n = 10)C) cell surface HLA-DR expression (specific mean fluorescence
intensity—SMFI n = 7) D), PDL1 expression (SMFI n = 7) E) PDL1 gene expression (n = 6). Data are
expressed as means ± SE of n independent experiments and analysed using a paired t-test * p<0.05, **
p<0.01. *** p<0.001.
doi:10.1371/journal.pone.0121527.g004
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Fig 5. Functional effect of PDL1 on T cell activation.MDMwere differentiated in the presence of 2 ng/ml
GM-CSF for 12 d prior to infection with 500 pfu/ml of H3N2 X31 influenza virus or a UV-irradiated aliquot of
virus (UVX31) for 2 h. Infected MDMwere transferred to a coated ELISpot plate and autologous lymphocytes
added and incubated for a further 22 h before IFNγ release was measured using ELISpot.A) 2.5 x 105
monocyte-depleted PBMC co-cultured with 5 x 104 autologous MDM not infected (NI) or treated with X31 or
UVX31(n = 5). B) 1 x 105 CD8+ T cells co-cultured with 5 x 104 autologous MDMNI or infected with X31 (n =
6) C) 1 x 105 CD8+ T cells co-cultured with 5 x 104 autologous MDM infected with X31 in the presence of 10
μg/ml anti-PDL1 antibody or isotype control (n = 5). Data are expressed as means ±SE of n independent
experiments and analysed using a paired t-test * p<0.05, ** p<0.01.
doi:10.1371/journal.pone.0121527.g005
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could be detected in any supernatants from uninfected or UVX31 exposed cells, but detectable
levels of IFNβ were released into the MDM culture supernatants in response to 24 h infection
with X31 (64.7 ± 52.5 pg/ml n = 6—Fig. 6B). Furthermore, infecting MDM with RSV also
caused a significant upregulation of IFNβ gene expression underlining the importance of this
cytokine in antiviral responses (Supporting Information Fig. 2B).
Significant increases in TNF and IL-6, but not IL-8 were also detected in supernatants from
X31 infected MDMs when compared to uninfected cells (Fig. 6B). To exclude a role for TNF
and IL-6 in the upregulation of PDL1 by macrophages we incubated MDM with TNF and IL-6
(both 10 ng/ml) for 24 h. TNF only induced a modest 1.5-fold increase in PDL1 surface expres-
sion, whilst IL-6 (10 ng/ml) had no effect on PDL1 expression (both n = 3—data not shown).
Role of virus-induced IFNβ in PDL1 expression
Since type I IFN expression was observed in response to influenza infection and previous stud-
ies have suggested that these cytokines could induce PDL1 expression[18,19], we investigated
whether rhIFNβ could induce PDL1 gene expression in our MDMmodel (Fig. 7A). We ob-
served a dose dependent-increase in PDL1 steady-state mRNA expression in response to IFNβ
after 24 h. Using 50 IU of rhIFNβ we saw a 2.9-fold increase in PDL1 gene expression increas-
ing to 4.3-fold at 100 IU of this cytokine.
We confirmed that influenza infection induces PDL1 via release of IFNβ by using short in-
terfering (si)RNA directed against IFNβ. After isolation, monocytes were cultured in GM-CSF
media for 11 d before incubating with scrambled siRNA or siRNA specific to IFNβ for 24 h in
GM-CSF media. MDM were infected with influenza as previously described and IFNβ and
Fig 6. Effects of influenza infection on MDM cytokine expression.MDMwere differentiated in the presence of 2 ng/ml GM-CSF for 12 d prior to infection
with 500 pfu/ml of H3N2 X31 influenza virus or a UV-irradiated aliquot of virus (UVX31) for 2 h. After washing, media was replaced and the cells incubated for
a further 22 h before supernatants and cells were harvested. Inflammatory cytokine expression was measured by A) real time PCR (IFNα, IFNβ n = 6) andB)
ELISA (IFNβ, TNFα, IL-6, IL-8 n = 6) N.D. = not detected. PCR data were normalised to β2MG and are expressed as mean fold induction over the non-
infected (NI) sample ± SEM of 6 independent experiments. ELISA data are expressed as means ±SE of 6 independent experiments. Data analysed using a
paired t-test. * p<0.05, ** p<0.01.
doi:10.1371/journal.pone.0121527.g006
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PDL1 mRNA expression were analysed using RT-PCR. Compared to the scrambled siRNA,
the specific RNA significantly inhibited IFNβmRNA expression by 37% (Fig. 7B). However de-
spite this limited inhibition of IFNβmessage, PDL1 mRNA was also significantly inhibited by
siRNA targeted against IFNβ, albeit to a lesser degree (14% inhibition).
Discussion
In the present study, we have demonstrated for the first time that in the acute phase of influen-
za infection macrophages are the primary cells in the human lung expressing PDL1. This mac-
rophage PDL1 expression has functional effects on autologous co-cultured CD8+ T cells.
Furthermore, these changes in PDL1 expression were not limited to NP1+ cells and hence ap-
pear to be mediated by release of IFNβ. Whilst the expression of PDL1 by human macrophages
Fig 7. Regulation of PDL1mRNA expression by influenza infection and IFNβ. A) PDL1 gene expression
was assessed in MDM differentiated in the presence of 2 ng/ml GM-CSF for 12 d before incubation with the
indicated doses of rhIFNβ for 24 h using RT-PCR (n = 5). B)MDMwere differentiated in the presence of 2 ng/
ml GM-CSF for 11 d before transfection with non-specific siRNA or siRNA specific for IFNβ in the presence of
GM-CSF for 24 h. MDMwere then infected with 500 pfu/ml of H3N2 X31 influenza virus or a UV-irradiated
aliquot of virus (UVX31) for 2 h. After washing, media was replaced and the cells incubated for a further 22 h
before cells were harvested for RT-PCR analysis of IFNβ and PDL1 mRNA expression (n = 6). PCR data
were normalised to β2MG and are expressed as mean fold induction over the non-infected (NI) sample ±
SEM of n independent experiments. Data analysed using a paired t-test * p<0.05, ** p<0.01.
doi:10.1371/journal.pone.0121527.g007
Viral Infection of Human Lung Macrophages
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has been investigated in response to both HIV and HCV infection, to our knowledge this is the
first investigation into the mechanisms of regulation of this molecule in human macrophages
infected with respiratory viruses, such as RSV and influenza.
Influenza infection of the airway is known to affect the macrophage functions of phagocyto-
sis and bacterial killing[20], but the question as to whether this was mediated by exogenous fac-
tors or by infection of the macrophages themselves has remained open. Early studies
demonstrated that virus-induced suppression of antibacterial defences was mediated by lym-
phocytes[21]. Subsequent studies have suggested that it is the cytokines released by lympho-
cytes, such as IFNγ and IL-10 that mediate the suppressive effects of virus[1,22–24]. However,
as influenza can infect and replicate in human alveolar macrophages[1], the reciprocal effects
of influenza-infected macrophages on lymphocyte function have remained largely unexplored.
The recent study by Erickson et al (2012) demonstrating that influenza infection of the lung
can upregulate PDL1 expression on both the airway epithelium and macrophages and that this
upregulation directly reduces CD8 T cell effector function highlights the dynamic relationship
between infected macrophages and T cells[7]. In contrast to this previous study we did not ob-
serve an up-regulation in epithelial PDL1 expression in response to influenza infection. How-
ever, Erickson et al (2012) analysed post-mortem lung samples from individuals with severe
influenza infection and thus the epithelial PDL1 expression observed may be at a more ad-
vanced stage of infection than our acute infection model can reflect[7]. Furthermore, our data
suggest the importance of macrophage PDL1 expression controlling T cell responses earlier on
in infection.
Expression of the T cell stimulatory molecules, HLA-DR and CD86, as well as the inhibitory
PDL1 protein was induced on influenza-infected macrophages. HLA-DR is a component of
the Major Histocompatibility Class (MHC) II complex involved in antigen presentation to
CD4+ T cells[25], whilst CD86 is classically associated with activation of the CD28 signalling
pathway[26]. Why the infected macrophage should upregulate both stimulatory and inhibitory
signals at the same time and the functional significance of this is open for speculation. Previous
investigators have suggested that there is equilibrium between expression of these markers and
the activation state, with inhibitory signalling being predominant when CD80/CD86 expres-
sion is low[27]. Selenko-Gebauer et al (2003) hypothesised that PDL1 expression may function
as an immunological rheostat to set a T cell activation threshold[27]. One further possibility is
suggested by the fact that both CD80 and CD86 can induce signalling by the inhibitory CTLA-
4 receptor on T cells as well as activating the CD28 pathway[28], therefore an inhibitory milieu
may be propagated via the infected macrophage. This may be especially important in the lung
as unconstrained inflammation can lead to lung function impairment and death[6].
Both type I and type II IFNs have been demonstrated to increase macrophage PDL1 expres-
sion[9]. We observed a trend towards increased blood T cell IFNγ release in response to the
UV-inactivated virus and it is likely that there are more virus-specific memory T cells in the
lung than in the blood. The release of IFNγ from lung resident memory T cells may therefore
explain the difference in PDL1 expression between tissue macrophages and isolated macro-
phages exposed to UVX31. However, as IFNγ was not expressed by isolated macrophages in re-
sponse to infection we focused on the role of type I IFNs in PDL1 expression in isolated cells.
Levels of IFNβ released from uninfected MDMwere below the limit of detection, whereas influ-
enza infection caused MDM to release measurable quantities of IFNβ and addition of as little as
50 IU of this cytokine caused an increase in PDL1 mRNA expression. This amount of IFNβ cor-
responds to approximately 250 pg of IFNβ which is within the same order of magnitude as that
detected from our infected-MDM by ELISA. Furthermore, we have used siRNA targeted against
IFNβ to demonstrate a role for this cytokine in the influenza-induced expression of PDL1. Sig-
nificant attempts to optimise the efficiency of the knockdown by varying the amounts of siRNA
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and transfection reagent and the time of siRNA addition, but we were unable to improve the
knockdown beyond a maximum of approximately 45%. It is possible that knockdown could be
improved further by reducing the number of cells to be transfected but in this investigation we
had to strike a balance between efficient siRNA transfection and optimized influenza infection.
We therefore opted to retain the conditions optimal for influenza infection. Despite the moder-
ate knockdown of IFNβmRNA induced by the specific siRNA, PDL1 could still be significantly
inhibited. This effect seems to be specific to IFNβ as in preliminary experiments we did not ob-
serve any effect of IFNα knockdown on PDL1 expression (data not shown). These observations
are in line with previous work showing a significant increase in PDL1 expression on blood
monocytes in multiple sclerosis patients undergoing IFNβ therapy[19].
The data presented herein may have implications for understanding the mechanisms of the
virus-induced exacerbations of chronic respiratory diseases, such as severe asthma[29]. Asthma
has long been associated with a skewing of lung immunity away from a Th1 (i.e. IFNγ produc-
ing) response to a high Th2 (i.e. IL-4/13 producing) response[30] and more recent work has
demonstrated no significant induction of IFNγ in BAL cells from asthma patients experimen-
tally challenged with rhinovirus[31]. Additionally, previous work has demonstrated a defect in
both epithelial[32,33] and bronchoalveolar lavage cell[29] production of type I and type III
IFNs in asthma in response to viral infection. Thus, in addition to the increase of viral replica-
tion resulting from decreased IFN production, the worsening of symptoms and increased in-
flammatory burden associated with asthma exacerbations may also be enhanced by decreased
IFN-induced PDL1 expression failing to adequately control the inflammatory response to
virus. Further work will be required to fully assess this possibility.
In conclusion, PDL1 expression is a primary response of monocytes/macrophages to viral in-
fection, whether that be in the liver[11], the blood[34] or the lung[7]. Moreover the role of IFNs
in upregulating PDL1 is not confined to monocytes/macrophages as IFNα and IFNγ have both
been shown to increase expression of PDL1 in hepatocytes[35]. Taken together with our data
using influenza and RSV, we suggest that this increased PDL1 expression is a common host re-
sponse to infection by different virus families. The question remains as to why this host response
mechanism in response to virus has developed and what its functional significance is? Perhaps it
is a means by which anti-viral responses can be restrained before the resulting inflammation
can cause too much tissue damage, as has been suggested in the liver[36]. Or, as has been sug-
gested for HIV, this mechanism has been subverted by the virus to prevent viral clearance[37].
In terms of influenza, PDL1 co-inhibition of virus-specific memory T cells may explain the par-
tial responses to immunization and poor cross protection from one influenza season to the next.
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S1 Methods. A full description of all the methods used to generate the data contained with-
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S1 Fig. Viability and cell surface marker expression of infected MDM.MDMwere infected
with increasing concentrations of X31 virus for 24 h and A) cells were analysed for viral NP-1
expression using flow cytometry and the percentage of NP1+ cells were gated using uninfected
cells as a negative control. B) supernatants were harvested for LDH analysis. Data are expressed
as means ± SE of 3 independent experiments. C—E) Histograms showing infected MDM ex-
pression of cell surface C) CD86 expression (specific mean fluorescence intensity—SMFI n =
4) and B) PDL2 expression (SMFI n = 7) E) CD14 expression (SMFI n = 4) expressed as means
± SE of n independent experiments.  P<0.01,  P<0.001
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S2 Fig. Infection of MDM by RSV. After infection with RSV, MDM were lysed and expression
of A) RSV-N gene at 2 h and 24 h post infection, B) IFNβ gene expression at 24 h and C) PDL1
gene expression were measured by RT-PCR and normalized to b2-microglobulin. Data are ex-
pressed as mean ± SE 2^-delta Ct values of 7 independent experiments.  P<0.05,  P<0.01.
(PPTX)
S3 Fig. Analysis of sensitivity of lymphocytes to X31 infection. A)MDMs or lymphocytes
were treated with UVX31 or X31 for 2 h before washing. 5 x 104 MDMs were added to wells of
an ELISPOT plate and were co-cultured with 2.5 x 105 lymphocytes. Wells not containing
MDMs (T only), and wells containing MDMs only were also measured for their ability to pro-
duce IFNγ. The ELISPOT plate was incubated at 37°C for 18 h before analysis. Mean and SEM
shown of 3 independent experiments. Paired students t test was performed. p< 0.05 (). B)
Graph showing mean percentage (± SE n = 3 independent experiments) infection of CD14+
monocytes, CD4+ and CD8+ T lymphocytes fractions of PBMC cultures exposed to increasing
concentrations of X31 influenza virus for 20 h as assessed by flow cytometry. C) Representative
FACS plots of 3 independent experiments at the highest dose of virus used are shown.
(PPTX)
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